Back to Search Start Over

Low and high serum IgG associates with respiratory infections in a young and working age population.

Authors :
Holma P
Pesonen P
Karjalainen MK
Järvelin MR
Väyrynen S
Sliz E
Heikkilä A
Seppänen MRJ
Kettunen J
Auvinen J
Hautala T
Source :
EBioMedicine [EBioMedicine] 2023 Aug; Vol. 94, pp. 104712. Date of Electronic Publication: 2023 Jul 13.
Publication Year :
2023

Abstract

Background: We investigated health consequences and genetic properties associated with serum IgG concentration in a young and working age general population.<br />Methods: Northern Finland Birth Cohort 1966 (NFBC1966, n = 12,231) health data have been collected from birth to 52 years of age. Relationships between life-long health events, medications, chronic conditions, lifestyle, and serum IgG concentration measured at age 46 years (n = 5430) were analysed. Regulatory mechanisms of serum IgG concentration were considered.<br />Findings: Smoking and genetic variation (FCGR2B and TNFRSF13B) were the most important determinants of serum IgG concentration. Laboratory findings suggestive of common variable immunodeficiency (CVID) were 10-fold higher compared to previous reports (73.7 per 100,000 vs 0.6-6.9 per 100,000). Low IgG was associated with antibiotic use (relative risk 1.285, 95% CI 1.001-1.648; p = 0.049) and sinus surgery (relative risk 2.257, 95% CI 1.163-4.379; p = 0.016). High serum IgG was associated with at least one pneumonia episode (relative risk 1.737, 95% CI 1.032-2.922; p = 0.038) and with total number of pneumonia episodes (relative risk 2.167, 95% CI 1.443-3.254; p < 0.001).<br />Interpretation: CVID-like laboratory findings are surprisingly common in our unselected study population. Any deviation of serum IgG from normal values can be harmful; both low and high serum IgG may indicate immunological insufficiency. Critical evaluation of clinical presentation must accompany immunological laboratory parameters.<br />Funding: Oulu University Hospital VTR, CSL Behring, Foundation for Pediatric Research.<br />Competing Interests: Declaration of interests PH: received scientific conference sponsorship from Octapharma and Takeda. TH: received scientific conference sponsorship from CSL Behring.<br /> (Copyright © 2023 The Author(s). Published by Elsevier B.V. All rights reserved.)

Details

Language :
English
ISSN :
2352-3964
Volume :
94
Database :
MEDLINE
Journal :
EBioMedicine
Publication Type :
Academic Journal
Accession number :
37453363
Full Text :
https://doi.org/10.1016/j.ebiom.2023.104712